ClinVar Miner

Submissions for variant NM_005957.5(MTHFR):c.680C>T (p.Thr227Met)

gnomAD frequency: 0.00001  dbSNP: rs748571395
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Centre for Inherited Metabolic Diseases, Karolinska University Hospital RCV000985005 SCV001554468 pathogenic Homocystinuria due to methylene tetrahydrofolate reductase deficiency 2021-04-07 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000985005 SCV003492437 pathogenic Homocystinuria due to methylene tetrahydrofolate reductase deficiency 2024-01-22 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 227 of the MTHFR protein (p.Thr227Met). This variant is present in population databases (rs748571395, gnomAD 0.008%). This missense change has been observed in individual(s) with MTHFR deficiency (PMID: 7726158, 32939339; Invitae; external communication). This variant is also known as C692T. ClinVar contains an entry for this variant (Variation ID: 800827). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MTHFR protein function. For these reasons, this variant has been classified as Pathogenic.
Revvity Omics, Revvity RCV000985005 SCV003808995 uncertain significance Homocystinuria due to methylene tetrahydrofolate reductase deficiency 2021-08-31 criteria provided, single submitter clinical testing
Baylor Genetics RCV003461295 SCV004196391 pathogenic Neural tube defects, folate-sensitive 2023-10-28 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000985005 SCV005077183 pathogenic Homocystinuria due to methylene tetrahydrofolate reductase deficiency 2024-04-19 criteria provided, single submitter clinical testing Variant summary: MTHFR c.680C>T (p.Thr227Met), also reported as "C692T", results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251488 control chromosomes. c.680C>T has been reported in the literature in multiple homozygous individuals affected with Homocystinuria due to Methylene Tetrahydrofolate Reductase Deficiency (examples: Aljassim_2020, Goyette_1995). These data indicate that the variant is very likely to be associated with disease. At least one publication reports that enzyme activity in patient fibroblasts was <10% of normal activity (Goyette_1995). The following publications have been ascertained in the context of this evaluation (PMID: 32939339, 7726158). ClinVar contains an entry for this variant (Variation ID: 800827). Based on the evidence outlined above, the variant was classified as pathogenic.
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City RCV000985005 SCV001132934 pathogenic Homocystinuria due to methylene tetrahydrofolate reductase deficiency 2019-08-25 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.